Although the heritability of cognitive function in old age is substantial, genome wide-association studies (GWAS) have had limited success in elucidating its genetic basis, leaving a considerable amount of 'missing heritability'. Aside from single nucleotide polymorphisms (SNPs), GWAS are unable to assess other large sources of genetic variation, such as tandem repeat polymorphisms.
Introduction
Cognitive function is a key determinant of quality of life and independence in old age (Blazer et al., 2015; Cigolle et al., 2007; Pusswald et al., 2015) . The proportion of the world's elderly population is rapidly increasing with the number of people aged 65 years or older estimated to rise from 8.5% of the world's population in 2015 to 16.7% by 2050 (He et al., 2016) . Therefore, the necessity to understand and investigate the pathophysiology and risk factors of cognitive decline in the ageing population is urgent. The contribution of genetics to brain function in older adults is substantial (Deary et al., 2009; Lee et al., 2010; Plomin et al., 2008; Singer et al., 2006) . Numerous genome-wide association studies (GWAS) have identified several single nucleotide polymorphisms (SNP) associated with age-related cognitive decline (Lin et al., 2017) . The largest meta-analysis to date, investigating 57 population-based cohorts comprising a total of 300 486 participants aged between 16 and 102 years, reported 148 SNPs associated with general cognitive function at a genome-wide significance level. The maximum proportion of phenotypic variance in general cognition explained in three independent samples by a prediction score derived from these data ranged between 2.63-4.31% (Davies et al., 2018) , leaving a substantial proportion of unexplained or 'missing heritability'.
Despite their essential role in genetic research, GWAS are limited due to the fact that these studies cannot assess polymorphisms in tandem repeat sequences (Lander et al., 2001) . Nonetheless, 3% of genomic DNA consists of such repetitive DNA stretches and thus have a considerable impact on genetic variation (Hannan, 2010a (Hannan, , b, 2018 .
Nine hereditary neurodegenerative diseases, known as polyglutamine disorders, including
Huntington disease (HD), are the most prevalent disorders associated with tandem repeats (Mirkin, 2007; Shao and Diamond, 2007) . These diseases are caused by an elongated cytosine-adenineguanine (CAG) repeat sequence in the protein-coding region of the respective polyglutamine disease-associated gene (PDAG) ( Table 1 ) (Benton et al., 1998; Bettencourt et al., 2016; Chung et al., 1993; David et al., 1997; Del-Favero et al., 1998; Fan et al., 2014; Giunti et al., 1995; Johansson et al., 1998; Koide et al., 1999; La Spada et al., 1991; Maciel et al., 1995; Maruyama et al., 1995; Matilla et al., 1993; Matsuyama et al., 1997; Nagafuchi et al., 1994; Nakamura et al., 2001; Orr et al., 1993; Pulst et al., 1996; Sanpei et al., 1996; Zhuchenko et al., 1997) . The elongated repeat sequence is present from birth. However, symptoms usually do not arise until middle age, making age a prominent risk modifier for disease onset. Furthermore, aside from progressive motor defects and psychiatric disturbances, polyglutamine disorder symptoms often affect cognitive function.
Increasing evidence implicates the polyglutamine domains of PDAGs as key regulators of transcriptional regulation, synaptic plasticity, calcium homeostasis and mitochondrial energy production, dysregulation of which have been associated with cognitive ageing (Burke and Barnes, 2006; Hands et al., 2008; Paulson et al., 2017) . However, to what extent more common CAG repeat length variations in PDAGs are associated with cognitive decline in older adults and changes in relevant brain structures, is still unknown. Since polyglutamine diseases are caused by expanded repeat sequences, the most rational hypothesis would be that larger repeat numbers in PDAGs are associated with a worse cognitive function. However, previous studies demonstrated more complex, non-linear associations between CAG repeat size variations, and neurodegenerative and neuropsychiatric disorders (Gardiner et al., 2019b; Gardiner, S. L. et al., 2017a; Gardiner, S. L. et al., 2017c; Stuitje et al., 2017) . Therefore, in this study, we aimed to assess the association of cognitive function in older adults with the CAG repeat number in the nine known PDAGs, investigating different linear and non-linear associations in an unbiased fashion.
Subjects and Methods

Subjects
The nine known PDAGs (including ATXN1, ATXN2, ATXN3, CACNA1A, ATXN7, TBP, HTT, ATN1 and AR) were genotyped in all participants with sufficient amounts of DNA available from blood samples of the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) study. This well characterized cohort included 5 786 men and women between 70-83 years old with a pre-existing vascular disease or a raised risk for such a disease. The study originally was a prospective multicentre randomized placebo-controlled trial to assess the effect of treatment with pravastatin on the risk of major vascular events in the elderly. Previous research showed that the treatment with pravastatin in this cohort did not affect cognitive decline or brain volume (ten Dam et al., 2005; Trompet et al., 2010) .
Participants were recruited from Scotland ( n=2 517), Ireland (n=2 173) and the Netherlands (n=1 096). All participants were Caucasian and none were diagnosed with a polyglutamine disease. The study was approved by the institutional ethics review boards of all centres and informed consent was obtained from all participants (Shepherd et al., 2002) .
Cognitive function assessment
The Mini-Mental State Examination (MMSE) was used to assess global cognitive function. To measure various cognitive domains, four neuropsychological tests were administered to all subjects.
The Stroop-Colour-Word test was applied to assess executive function by evaluating attention span.
The outcome parameter for this test was the total number of seconds required to complete the third Stroop card (Stroop III). The Letter-Digit Coding Test (LDT) was applied to assess processing speed with the total number of correct entries completed in 60 sec as outcome. Memory was assessed with the 15-Picture Learning test (PLT) which measured immediate and delayed recall. Immediate recall was defined as the accumulated number of pictures recalled over three learning trials and delayed recall was defined as the number of pictures recalled after 20 min. Cognitive function was measured at baseline, after 9, 18 and 30 months of follow-up, and at the end of the study which varied between participants (36-48 months) (Shepherd et al., 1999) .
Imaging characteristics
Two successive magnetic resonance imaging (MRI) scans of the brain were obtained from a total of 646 Dutch participants with a follow-up of 30 months. MRI was performed on a system operating at 1.5 T field strength (Philips Medical Systems) and proton desity-T2/dual fast-spin-echo images were collected (TE, 27/120 ms; TR, 3000 ms; echo train length factor, 10; 48 contiguous 3-mm slices; matrix 256x256; FOV, 220) (ten Dam et al., 2005 . The volumes of the right and left subcortical structures were summed to generate one overall volume per subcortical structure.
Genotyping
To determine the CAG repeat length in the nine PDAGs for each individual, a polymerase chain reaction (PCR) was performed in a TProfessional thermocycler (Biometra, Westburg) with labelled primers flanking the CAG stretch of the PDAGs (Biolegio) (Supplemental Table 1 ). The PCR was performed using 10 ng of genomic DNA, 1x OneTaq mastermix (New England Biolabs, OneTaq Hot start with GC Buffer master mix), 1 µl of primer Mix A or B (Supplemental Table 1 ) and Aqua B.
Braun water to a final volume of 10 µl. The PCR was run with 27 cycles of 30 seconds, denaturation at 94°C, one minute of annealing at 60°C and two minutes elongation at 69°C, preceded by five minutes of initial denaturation at 94°C. Final elongation was performed at 69°C for five minutes.
Every PCR included a negative control without genomic DNA and a reference sample of CEPH 1347-02 genomic DNA. The PCR products were run on an ABI 3730 automatic DNA sequencer (Applied Biosystems) and analysed using the GeneMarker software version 2.4.0. For every analysis, we included three controls with known CAG repeat lengths for each PDAG to assure every run was performed reliably. All assessments were performed by randomizing study participants across batches while researchers were blinded with respect to the clinical information.
Statistical Analysis
To analyse the association between the CAG repeat number in PDAGs and cognitive function in older adults, we initially performed a principal component analysis to aggregate the different cognitive test scores into one outcome. However, the first principal component of 'cognition at baseline' and 'cognition over time' both did not explain more than 52.7 -55.8% of the variance. Therefore, we did not find these components to summarize the actual outcomes reliably. Instead, we calculated Zscores for all cognitive assessment test outcomes, including MMSE score, total number of seconds to complete Stroop III, total number of correct entries in the LDT and total number of pictures recalled in the immediate and delayed recall of the PLT. The data of Stroop III had a skewed distribution and thus was log-transformed, and inverted as higher scores indicated a worse performance. We summed up the Z-scores of the data derived at baseline to create a baseline summary score of cognitive function. A higher score indicated a better cognitive function. Generalized linear mixedeffect models with this summary score as dependent variable were applied to assess the association between the CAG repeat numbers in the PDAGs and cognitive function at baseline. Country (i.e.
Scotland, Ireland or the Netherlands) was set as random effect to account for potential population stratification and the CAG repeat number of both alleles were set as fixed effects. Each allele was defined as either 'short' or 'long' relative to the CAG repeat number in the other allele. The alleles were defined as such, because previous research has shown the 'shorter' and the 'longer' allele to have different associations with various outcomes, such as age of onset in polyglutamine diseases, body mass index and depression (Aziz et al., 2009; Gardiner et al., 2018; Gardiner, S. L. et al., 2017b; Gardiner, Sarah L. et al., 2017; Stuitje et al., 2017) . The CAG repeat size in the X-linked AR gene was examined by 1) analysing men and women separately and 2) investigating either the shorter or the longer AR allele separately in men and women combined. To assess potential interaction or nonlinear effects (Gardiner, S. L. et al., 2017b; Tezenas du et al., 2014) , we also included a product term of both alleles and a quadratic term for each allele as fixed effects.
To assess the association between the CAG repeat number in the PDAGs and the decline in cognitive function over time, we created a summary score of the cognitive function over time by adding the Zscores of the data derived per visit (the Z-scores were created with respect to the baseline distribution). Consequently, each individual had one cognitive summary score per visit. We then applied similar generalized linear mixed-effects models with this summary score as dependent MRIs were only performed in Dutch participants and MRI parameters were not assessed at more than one point in time. Therefore, linear regression instead of generalized linear mixed-effect modelling, was applied to analyse the association between the different imaging parameters and the CAG repeat number in the PDAGs. The MRI variables were set as dependent variables and the CAG repeat numbers of both alleles, including the product term and the quadratic terms were included as independent variables.
In order to assess whether CAG repeat variation in the PDAGs could explain a significant additional amount of variation in the respective dependent variable, we first performed an omnibus test (i.e., a restricted F-test) per PDAG by including as independent variables all terms associated with the respective locus (i.e., CAG repeat size of both alleles, their interaction, a quadratic term for each allele and the product of follow-up time and the CAG repeat number in both alleles if applicable).
We applied a false discovery rate (FDR) correction to account for multiple testing, assuming nine independent tests with the FDR q set at .05, to determine whether an omnibus test result was significant (Benjamini and Hochberg, 1995) . Only in cases where an omnibus test was statistically significant after multiple testing correction, we performed post hoc tests by assessing the effect of the individual PDAG alleles and their associated higher-order terms in order to gain more insight into the nature of the association. Non-significant higher order terms were removed and the analyses were repeated to arrive at a final model. All final models were corrected for age, sex and population structure using principal components generated from genome wide genotyping data (Shiffman et al., 2012) . Although having a pre-existing vascular disease or a raised risk for such a disease probably has an effect on cognition and cognitive decline, this variable is unlikely to be associated with CAG repeat polymorphisms in PDAGs and can thus not be considered a confounder. Therefore, we did not correct for this covariate. To reduce multicollinearity, the CAG repeat numbers were centred around their respective means. To account for potential effects of heteroscedasticity and influential points, all statistical significance tests were based on robust estimators of standard errors and all CAG repeat lengths with a frequency of less than ten for the analyses of cognitive function or less than five for the analyses of imaging characteristics, were excluded (Supplemental Table 2 
and 3).
We calculated the R 2 per PDAG for each final model to determine the amount of variance explained by each gene (Nakagawa and Schielzeth, 2013) .
We determined the amount of variance in cognitive function explained by the significant repeat polymorphisms in total by incorporating the fixed effects of the final significant models with cognitive function over time as outcome into one model and calculating its marginal R 2 . To illustrate this combined effect we 1) calculated the residual cognitive function after regression on age, sex, follow-up time and principal components generated from genome wide genotyping data as fixed factors, and country and the follow-up time as random factors in a generalized mixed-effects model,
2) performed linear regression with the CAG repeat sizes of the significant PDAGs, including all interaction and non-linear effects which were identified as significant in the main analyses as independent variables and the residual cognitive function as the outcome, 3) divided the total cohort in two equally sized groups based on the predicted values of this regression model, 4) plotted the average residual cognitive function of these two groups. All data are displayed as means and 95% confidence intervals (CIs) unless otherwise specified. All analyses were performed in STATA/SE version 14.2 (StataCorp LLC).
Results
We were able to determine the CAG repeat length of between 5 285-5 633 individuals for each gene.
The lacking samples were due to too little available DNA and were missing completely at random (Table 1 ). In total, we found 79 participants with CAG repeat numbers within the pathological range of at least one PDAG, including ATXN1 (n=4), ATXN2 (n=2), TBP (n=66) and HTT (n=7). For a more extensive report on these findings, please see our previous publication (Gardiner et al., 2019a ).
Between 0.1 to 2.9% of the cases per gene were excluded from the analyses of cognitive function because of CAG repeat numbers with a frequency of less than ten and between 0.8 to 7.2% of the cases were excluded from the analyses of the imaging parameters due to CAG repeat numbers with a frequency of less than five (Supplemental Table 2 and 3). The cohort characteristics are summarized in Table 2 . The summary scores of baseline cognitive function and cognitive function over time ranged from -12.55 to 9.92 and from -16.30 to 10.15, respectively.
Baseline cognitive function was associated with CAG repeat variations in AR in women
Initial omnibus tests with cognitive function at baseline as the outcome were significant for ATXN2
and TBP (p ≤ .008). In addition, the omnibus tests for the shorter AR allele assessed in both sexes and the longer AR allele assessed in women only, were statistically significant (p ≤ .004). The post hoc tests subsequently indicated a significant non-linear association between cognitive function at baseline and the CAG repeat number in the longer AR allele in women (Table 3) . Both relatively small and relatively large CAG repeat numbers in the longer AR allele in women were associated with a higher cognitive function at baseline (Figure 1) . A CAG repeat number of about 22-23 in the longer AR allele was associated with the lowest cognitive function at baseline. These results did not change materially after correcting for age, sex and population structure ( Table 3) . Post hoc tests for ATXN2, TBP and the shorter AR allele assessed in both sexes did not indicate a significant association with cognitive function at baseline.
3.2 The CAG repeat variations in TBP, HTT and AR were associated with cognitive function over time
The omnibus tests with cognitive function over time as outcome were significant for ATXN2, TBP and HTT (p < .005). Furthermore, the omnibus tests were statistically significant, when the longer and the shorter AR allele were assessed separately in both sexes, and when both AR alleles were assessed in women only (p < .009). Subsequent post hoc tests indicated a significant association between cognitive function over time and CAG repeat variations in the longer TBP allele, the longer HTT allele, the longer AR allele assessed in only women and the shorter AR allele assessed in both sexes ( Table 3) . Larger CAG repeat numbers in the longer TBP allele were associated with a lower summary score of cognitive function at each point in time that cognitive function was assessed. This association is visualized by observing that as individuals age the summary score of cognitive function declines, but the negative association with the CAG repeat number in the longer TBP allele remains apparent in each age group (Figure 2A) . Similarly, in each age group the CAG repeat number in the longer HTT allele and the longer AR allele in women had a non-linear associations with cognitive function over time. Both relatively small and relatively large CAG repeat numbers in the longer HTT allele were associated with a lower cognitive function ( Figure 2B ). Conversely and similar to its association with cognitive function at baseline, smaller and larger CAG repeat numbers in the longer AR allele assessed in women were associated with a higher cognitive function ( Figure 2C) . The CAG repeat number in the shorter AR allele in both sexes was associated with the rate of decline in cognitive function, based on the significant association between the interaction term of the CAG repeat number in the shorter AR allele and follow-up time (Table 3) . Larger CAG repeat numbers in the shorter AR allele assessed in both sexes was associated with a faster decline in cognitive function over time ( Figure 2D ). These associations remained significant and largely unaltered after correction for age, sex and population structure. Post hoc tests for ATXN2 and the longer AR allele assessed in both sexes did not indicate a significant association with cognitive function over time.
In combination, CAG repeat polymorphisms in TBP, HTT and the shorter AR allele assessed in both sexes explained 0.49% of the total variance in cognitive function (Figure 3) . In this calculation, we did not incorporate the effect of the CAG repeat polymorphisms in the longer AR allele, because this effect was only significant when assessed in women.
3.3 CAG repeat variations in ATXN2, CACNA1A, ATXN7 and AR were significantly associated with brain stem and subcortical structure volumes
The MRI variables of which omnibus tests and subsequent post hoc tests indicated significant associations with CAG repeat polymorphisms in the PDAGs are presented in Table 4 . In women, the CAG repeat number in the longer AR allele had a non-linear association with the volume of the amygdala. Both smaller and larger CAG repeat numbers were associated with a higher volume of the amygdala (Supplemental Figure 1A) . The longer AR allele in both sexes had a similar non-linear association with the volume of the amygdala, the putamen and the thalamus (Supplemental Figures   1B, C and D) . In contrast, larger CAG repeat numbers in the shorter AR allele assessed in both sexes were associated with a smaller volume of the amygdala (Supplemental Figure 2) .
When the shorter CACNA1A allele had less than 11 repeats, larger CAG repeat numbers in the longer CACNA1A allele were associated with an increased volume the amygdala (Supplemental Figure 3A) .
CAG repeat variations in CACNA1A were also associated with the volume of the thalamus. Larger CAG repeat numbers in the shorter CACNA1A allele were associated with a larger thalamic volume (Supplemental Figure 3B) . The CAG repeat number in the longer ATXN2 allele and the shorter ATXN7 allele had inverse associations with the volume of the brain stem (Supplemental Figure 4A and B). The CAG repeat number in the shorter ATXN2 allele had non-linear associations with the volume of the putamen and the thalamus (Supplemental Figure 4C and D) . Both smaller and larger CAG repeat numbers in the shorter ATXN2 allele were associated with smaller volumes of both subcortical structures. The association between the CAG repeat number in ATXN2 and the increase in percentage of atrophy per year, the volume of the amygdala and the volume of the globus pallidus, and the association between the interaction of both ATXN7 alleles and the volume of the nucleus accumbens were mainly driven by a few influential points and, therefore, unlikely to be robust (Supplemental Figures 5A, B, C and 6 ). CAG repeat variations in the other PDAGs were not significantly associated with atrophy at baseline, grey matter volume, white matter volume, total brain volume, the volume of the hippocampus or the volume of the nucleus caudatus. All results remained materially unaltered after correcting for age, sex and population structure ( Table 4) .
Discussion
To our knowledge, this study is the first to investigate the association between CAG repeat variations within the 'normal' range of PDAGs and cognitive function in older adults. We found that CAG repeat number variations in TBP, HTT and AR were significantly associated with cognitive function independent of age. In addition, we found that the CAG repeat variations in the shorter AR allele were associated with the rate of cognitive decline. Together the CAG repeat polymorphisms in these genes explained about 0.49% of the variance in cognitive function. Furthermore, we found that CAG repeat polymorphisms in ATXN2, CACNA1A, ATXN7 and AR were significantly associated with the volume of the brain stem and several subcortical structures, including the amygdala, the thalamus and the putamen. Remarkably, the associations of AR repeat polymorphisms with cognitive function closely matched the associations between the AR repeat polymorphisms and MRI variables.
The maximum proportion of phenotypic variance in general cognition explained in three independent samples by a prediction score derived from data of 57 population-based cohorts evaluated in a meta-analysis, ranged between 2.63-4.31% (Davies et al., 2018) . In this study, we found that CAG repeat polymorphisms within the 'normal' range in the nine known PDAGs explained almost 0.49% of the variance in cognitive function. Although external validation of our results is warranted, this remarkable finding indicates the enormous potential of tandem repeat polymorphisms in the genetic research of cognitive function.
The polyglutamine stretch in HTT has been implicated previously as relevant for cognitive function.
Lee et al. reported that in children aged 6-18 years, larger CAG repeat numbers within the 'normal'
range in the longer HTT allele were associated with a higher general intelligence (IQ) . In addition, larger CAG repeat numbers in HTT were associated with increased grey matter volume in the globus pallidus (Muhlau et al., 2012) . Furthermore, organisms with a more complex central nervous system possess a higher number of repeats in HTT (Cattaneo et al., 2005; Tartari et al., 2008) . However, CAG repeat numbers in HTT beyond 35 repeats cause HD, which is characterized among other things by cognitive deterioration. These facts imply a curvilinear association between cognitive function and the number of CAG repeats in HTT with the suggestion of an optimal number of CAG repeats. Indeed, here we found that CAG repeat numbers in the longer HTT allele had a nonlinear association with cognitive function in older adults with relatively small and large CAG repeat numbers being associated with a lower cognitive function, and the optimal CAG repeat number being around 22 repeats. This non-linear association has also been suggested by other groups (Lee et al., 2018) .
Comparable to HTT, the number of CAG repeats in the X-linked AR gene increases as organisms gain a more complex central nervous system throughout evolution (Choong et al., 1998; Djian et al., 1996; Hong et al., 2006) . In addition, very short CAG repeat sequences in AR were associated with very severe mental retardation (Kooy et al., 1999) . However, in older men, larger CAG repeat numbers in AR were found to accelerate cognitive decline (Gardiner et al., 2019b; Yaffe et al., 2003) .
Thus, these findings suggest a complex association between cognitive function and CAG repeat variations in AR, which is reflected in our findings. CAG repeat variations in the longer AR allele had a non-linear association with cognitive function and the volumes of the amygdala, the putamen and the thalamus. Both relatively small and relatively large CAG repeat numbers were associated with a higher cognitive function and larger volumes of the respective subcortical structures. The first part of this non-linear association is reflected in the association between the CAG repeat number in the shorter AR allele, and the rate of cognitive decline and the volume of the amygdala. Relatively short CAG repeat numbers in the shorter AR allele were associated with a slower decline in cognitive function and a larger volume of the amygdala. As the CAG repeat number in the shorter AR allele increased the rate of cognitive decline increased and the volume of the amygdala decreased, similar to the first part of the non-linear association between the longer AR allele and cognitive function.
This complex association between cognitive function and CAG repeat variation over the entire 'normal' range in AR is intriguing and warrants more detailed investigation in future experiments.
CAG repeat numbers in TBP exceeding 44 repeats are associated with the development of spinocerebellar ataxia type 17 (SCA17), an autosomal dominant inherited neurodegenerative disease characterized by cerebellar ataxia, involuntary movements, psychiatric symptoms and cognitive decline eventually resulting in dementia (Zuhlke and Burk, 2007) . Previously, we demonstrated that larger CAG repeat numbers in TBP within the 'normal' range were associated with a higher risk of lifetime depression (Gardiner, S. L. et al., 2017a) . This finding supports the notion that the cut-off of disease causing CAG repeats in SCA17 might not be as rigorous as previously suggested and that depressed individuals with a CAG repeat number within this large 'normal' CAG repeat range could have a less severe form of SCA17 characterized only by psychiatric symptoms. Here we found that larger CAG repeat numbers in the longer TBP allele were associated with a decreased cognitive function. Similarly, this finding suggests that the pathology caused by larger CAG repeat numbers in TBP operate in a more continuous and gradual fashion rather than on a dichotomous scale.
The ageing brain is characterized by several cellular and molecular changes, many of which overlap with pathways affected in polyglutamine disorders (Burke and Barnes, 2006; Hands et al., 2008) . For instance, processes dysfunctional in HD, such as transcriptional abnormalities, dysregulation of the chaperone network, alterations of cellular protein degradation systems, mitochondrial deficits, unbalanced redox-homeostasis, and changes in axonal transport and synaptic function have all been linked to ageing (Hands et al., 2008) . Aside from the polyglutamine disease spinocerebellar ataxia type 2, polymorphisms in ATXN2 have also been associated with other neurodegenerative diseases, such as amyotrophic lateral sclerosis and progressive supranuclear palsy (Pulst et al., 1996; Ross et al., 2011; Sproviero et al., 2017) . In addition, in a large GWAS, the ATXN2 locus was associated with longevity (Fortney et al., 2015) . Therefore, we can hypothesize that polymorphisms in ATXN2 increase the susceptibility for certain neurodegenerative diseases and neurodegeneration in general through similar cellular pathways and perhaps also resulting in alterations in different cerebral structures, such as the volume of the brain stem, the putamen and the thalamus. Yeast strains lacking Sgf73 are exceptionally long-lived. Sgf73 is a yeast orthologue of ataxin-7 (ATXN7), the protein encoded by ATXN7 (Helmlinger et al., 2006; McCormick et al., 2014) . ATXN7 is a member of the TBP (TATA-binding protein)-free TAF (TBP-associated factor) complex (TFTC) and the SPT3/TAF9/GCN5 acetyltransferase (STAGA) complex, co-activators required for the transcription of RNA polymerase II-dependent genes (Helmlinger et al., 2006) . We found that larger CAG repeat sequences in ATXN7 were associated with a smaller volume of the brain stem. This finding suggests that polyglutamine elongations might very well affect ATXN7 function within TFTC and STAGA and consequently affect the volume of cerebral structures and consequentially longevity. Several studies have also shown that aged neurons suffer from an increased Ca 2+ conduction (Foster and Norris, 1997; Toescu et al., 2004) . CACNA1A encodes the α1A subunit of P/Q-type voltage-dependent calcium channel (Zhuchenko et al., 1997) . This subunit contains the pore forming structure of the calcium channel and is responsible for channel gating, permeability, and voltage dependent activation and inactivation (Catterall, 2000) . Although the role of the polyglutamine domain in the function of the channel continues to be debated, the associations we found between the CAG repeat number in CACNA1A and the volume of the brain stem in the older adults, indicate a potential modifying role. Collectively, these findings illustrate the close similarities between characteristics of the ageing brain and the pathophysiology of polyglutamine diseases. Combined with the associations we found between the CAG repeat number in ATXN2, CACNA1A, ATXN7, TBP, HTT and AR, and cognitive function, the volume of the brain stem as well as several other subcortical structures in older adults, these findings implicate an important role for PDAGs in the normal ageing process of the human brain.
In total, we found 79 individuals with a CAG repeat number in the pathological range of at least one PDAG. None of the included participants had been diagnosed with a polyglutamine disease.
Unfortunately, however, follow-up data on these participants was not available. Therefore, we were neither able to determine whether these participants would have developed a polyglutamine disease at a later time, nor distinguish between the cognitive decline as an early sign of a late-onset polyglutamine disease or part of 'normal' aging. However, the fact that we found the association between cognitive function in old age and CAG repeat polymorphisms in different PDAGs to extend well into the normal range, suggests that independent of polyglutamine disease development CAG repeat polymorphisms are associated with cognitive function in old age.
A limitation of our work is that we conducted our study in a large cohort containing participants from three European countries, a relatively heterogeneous population. To adjust for this, we corrected for potential population stratification. Results from heterogeneous cohorts can be generalized more easily. Nonetheless, to increase the robustness of our findings, additional research should be conducted in other study populations. Another limitation involves the fact that MRI data were only available for a subset of our cohort and the available data consisted solely of structural measurements. Unfortunately, we did not have diffusion tensor imaging data or functional measurements at our disposal, which could potentially have led to more insight into the biological foundation of the significant associations we found between CAG repeat polymorphisms and cognitive function.
In conclusion, we found that CAG repeat number variations in TBP, HTT and AR were significantly associated with cognitive function in older adults, jointly explaining nearly 0.49% of the variance.
Furthermore, CAG repeat variations in ATXN2, CACNA1A, ATXN7 and AR were associated with the volume of the brain stem and several subcortical structures. Our results demonstrate the importance of tandem repeat polymorphisms as novel, but hitherto underappreciated, modifiers of cognitive ageing and emphasize the role of PDAGs in healthy brain function. The association between cognitive function at baseline and the CAG repeat number in the longer AR allele in women. The cognitive function assessed at baseline had a non-linear association with the CAG repeat number in the longer AR allele in women. In women, both relatively small en relatively large CAG repeat numbers were associated with a higher cognitive function at baseline. Figure 2 . The association between cognitive function over time and the CAG repeat number in TBP, HTT and AR. A. Larger CAG repeat numbers in the longer TBP allele were associated with a lower cognitive function. This association remained significant throughout the entire assessment period and is thus visible in all age groups. B. Both relatively small and relatively large CAG repeat numbers in the longer HTT allele were associated with a decreased cognitive function. This association was also present at all assessment time-points and can be observed over the three different age groups C. Relatively small and relatively large CAG repeat numbers in the longer AR allele assessed in women were associated with a higher cognitive function. This association was again consistent over the entire assessment period and all age groups. D. CAG repeat numbers > 21 CAG repeats were associated with a faster decline in cognitive function over time compared to CAG repeat numbers ≤ 21. 
